<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-16T21:35:23+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>基因治疗市场规模持续扩大，预计2027年将达到356.7亿美元丨医麦新观察</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/UTR8pWnAPZJWJXu8ookSqA</id>
    <link href="https://mp.weixin.qq.com/s/UTR8pWnAPZJWJXu8ookSqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature子刊：外泌体药物逐渐步入临床开发阶段，成为下一代潜在的重磅药物载体技术丨医麦新观察</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/PcxyYnLLGexPr6KEE30JiA</id>
    <link href="https://mp.weixin.qq.com/s/PcxyYnLLGexPr6KEE30JiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH 2020丨邱录贵教授：CNCT19联合ASCT在复发/难治性大B细胞淋巴瘤中疗效及安全性良好</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/u_Ttp1C5qpcq-c8Fr8LapQ</id>
    <link href="https://mp.weixin.qq.com/s/u_Ttp1C5qpcq-c8Fr8LapQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>翟博教授：实体瘤CAR-T治疗——远方千万里，已经在路上</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/2dWXvPW25tRoqhhmDFwTyA</id>
    <link href="https://mp.weixin.qq.com/s/2dWXvPW25tRoqhhmDFwTyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」八通生物董事长胡小龙：从检测创新入手，应对新冠疫情持久战</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/koKmPctBYjlGGfRQPkjlZA</id>
    <link href="https://mp.weixin.qq.com/s/koKmPctBYjlGGfRQPkjlZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>相约深圳｜新一代生物技术革命到来！看合成生物学如何颠覆人类认知</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/PNJt9ktMhxffi_2wqxTIpw</id>
    <link href="https://mp.weixin.qq.com/s/PNJt9ktMhxffi_2wqxTIpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨宜明细胞完成1.2亿元A轮融资，全面提高GMP病毒载体产能</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/iHNo_yQRE_CkQCcBKqVeFQ</id>
    <link href="https://mp.weixin.qq.com/s/iHNo_yQRE_CkQCcBKqVeFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>传奇生物的CD4 CAR-T获FDA批准临床丨医麦猛爆料</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/V5U0TWOZPJ6tOtFwCBwWFQ</id>
    <link href="https://mp.weixin.qq.com/s/V5U0TWOZPJ6tOtFwCBwWFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新增线上直播丨人类遗传资源与生物医药注册法规官方解读</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/HQ91zQiVr3TrS2baBtwyHg</id>
    <link href="https://mp.weixin.qq.com/s/HQ91zQiVr3TrS2baBtwyHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>​徐开林教授：CAR-T存在前线治疗的可能，有待解决副作用和高费用问题</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/JcXMcwp6_GGwQeDsJWBK6g</id>
    <link href="https://mp.weixin.qq.com/s/JcXMcwp6_GGwQeDsJWBK6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨IPO狂潮继续，又有4家公司上市</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/ST-jJk0JINavL1vaIH8HyQ</id>
    <link href="https://mp.weixin.qq.com/s/ST-jJk0JINavL1vaIH8HyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」博润阳光总经理詹卫红：脱下白大褂投身医药行业，目标还是治病救人</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/qZ6KUjmZb8Lvzo2sCYWw-A</id>
    <link href="https://mp.weixin.qq.com/s/qZ6KUjmZb8Lvzo2sCYWw-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」沙砾生物创始人刘雅容：TIL疗法有望突破实体瘤细胞治疗现状，A轮融资将用于全面推进一代TIL在中国的临床开发</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/4j4mMWPxK0_wNzDKsHYUbg</id>
    <link href="https://mp.weixin.qq.com/s/4j4mMWPxK0_wNzDKsHYUbg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>癌症疫苗联合T细胞疗法，胶质母细胞瘤双重免疫疗法即将启动关键性临床试验丨医麦猛爆料</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/HWkkXLf9086N1lZBBFZzpA</id>
    <link href="https://mp.weixin.qq.com/s/HWkkXLf9086N1lZBBFZzpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO：全球第三款获批上市的GD2抗体公布临床数据，拯救患病儿童丨医麦猛爆料</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/94ENe2gp6Gd8GWGV7hpzFw</id>
    <link href="https://mp.weixin.qq.com/s/94ENe2gp6Gd8GWGV7hpzFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>埃格林医药正式启动中/重度新冠肺炎口服治疗药的临床Ⅰ期试验丨医麦猛爆料</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/il2a7LJYX_tvy4DDw2QoWA</id>
    <link href="https://mp.weixin.qq.com/s/il2a7LJYX_tvy4DDw2QoWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>薛胜利教授：敬畏疾病 感恩患者，不断探究更优的治疗方案</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/Qeo5vaq_Fi6apZXiHeCuRA</id>
    <link href="https://mp.weixin.qq.com/s/Qeo5vaq_Fi6apZXiHeCuRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T进入加拿大安大略省医保，YESCARTA四年真实世界数据表现卓越丨医麦猛爆料</title>
    <updated>2020-12-13T08:42:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/7rBGYf6fY1SK2fH1lp1C_w</id>
    <link href="https://mp.weixin.qq.com/s/7rBGYf6fY1SK2fH1lp1C_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>VEGFR2单抗联合K药治疗转移性三阴性乳腺癌显示出积极的有效性和安全性丨医麦猛爆料</title>
    <updated>2020-12-13T08:42:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/ztcVG4wCkL0vOyMY8rF1Zg</id>
    <link href="https://mp.weixin.qq.com/s/ztcVG4wCkL0vOyMY8rF1Zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DNA治疗性疫苗显示出对HPV阳性相关肛门癌前病变的有效性和安全性丨医麦猛爆料</title>
    <updated>2020-12-13T08:42:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/Ubof49oTdhUnh2xk-kwizg</id>
    <link href="https://mp.weixin.qq.com/s/Ubof49oTdhUnh2xk-kwizg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>